Insulet Corp
NASDAQ:PODD
Insulet Corp
Cash from Operating Activities
Insulet Corp
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Insulet Corp
NASDAQ:PODD
|
Cash from Operating Activities
$145.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
32%
|
CAGR 10-Years
46%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Insulet Corp's Cash from Operating Activities?
Cash from Operating Activities
145.7m
USD
Based on the financial report for Dec 31, 2023, Insulet Corp's Cash from Operating Activities amounts to 145.7m USD.
What is Insulet Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
46%
Over the last year, the Cash from Operating Activities growth was 22%. The average annual Cash from Operating Activities growth rates for Insulet Corp have been 20% over the past three years , 32% over the past five years , and 46% over the past ten years .